Patent · US Expired

Use of diphosphonic acids or the physiologically acceptable salts or esters thereof in the preventive treatment of after-effects resulting from enlargement or replacement of the bladder

US6476008B1 · kind B1 · utility

0Cited by

9References

6Claims

0Family size

Assignee

Roche Diagnostics GMBH · DE

Inventors

Frieder Bauss · Lambsheim, DE
Drasko Brkovic · Leimen, DE

Key dates

Filing date	Dec 27, 1999
Grant date	Nov 5, 2002
Priority date	—
Expiry date	Dec 27, 2019

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P13/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to use of diphosphonic acids or physiologically compatible salts or esters thereof for preventive treatment of disturbances to ossary mineralization which may occur after operative extension of the urine bladder by augmentation plasties or replacement of the urine bladder by replacement plasties but often do not appear until years after the operation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.